Bond stimulated engineered macrophages with light, then made the cells wait for different periods of time. She then presented ...

The drug that they designed already has a licence, which they say should hasten the approval process ... it stops cancer cells from hiding and sending out "eat me not" signals to macrophages.

they also have the potential to promote cancer growth. Understanding the signaling pathways that control macrophage behavior is critical for designing new therapies. “Ultimately, I try to get immune ...

Carisma Therapeutics is developing a unique, differentiated immuno-oncology (IO) treatment for solid tumors based on chimeric antigen receptor macrophages (CAR-M). Current IO treatments have ...

It is thought that blockade of that interaction can restore the ability of macrophages to phagocytose or 'eat' cancer cells and – crucially – may offer a new option for the sizeable proportion ...